9-29-2022: Fukuoka, Japan: Shohei Yoshimoto says Actemra is helpful against bone loss involving a benign tumor: "Stromal fibroblasts expressed RANKL in the tumor microenvironment of ameloblastoma in vivo" https://t.co/B70p5DaK79 https://t.co/OoHBNCoZUr h
#TISSUEBARRIERS Tocilizumab promotes repair of spinal cord injury by facilitating the restoration of tight junctions between vascul… https://t.co/BHHNRtUENU
"Actemra has treated neurological diseases in recent years...In this study, Actemra was called in to rescue mice from deliberately-induced spinal cord injuries...significant increase in axon regeneration, recovery of motor function, and less fibrotic scar"
RT @Axon_reg_papers: Tocilizumab promotes repair of spinal cord injury by facilitating the restoration of tight junctions between vascular…